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Digital breast tomosynthesis (DBT) is an alternative tool for breast cancer screening;
however, the magnitude of peripheral organs dose is not well known. This study
aimed to measure scattered dose and estimate organ dose during mammography
under conventional (CM) and Tomo (TM) modes in a specific DBT system. Optically
stimulated luminescence dosimeters (OSLDs), whose responses were corrected using
a parallel‐plate ionization chamber, were pasted on the surface of custom‐made
polymethyl methacrylate (PMMA) and RANDO phantoms to measure entrance sur-
face air kerma (ESAK). ESAK measurements were also acquired with a 4.5‐cm thick
breast phantom for a standard mammogram. Organ dose conversion factors (CFD)
were determined as ratio of air kerma at a specific depth to that at the surface for
the PMMA phantom and multiplied by the ratio of mass energy absorption coeffi-
cients of tissue to air. Normalized eye lens and thyroid gland doses were calculated
using the RANDO phantom by multiplying CFD and ESAK values. Maximum variabil-
ity in OSLD response to scatter radiation from the DBT system was 33% in the W/
Rh spectrum and variations in scattered dose distribution were observed between
CM and TM. The CFD values for eye lens and thyroid gland ranged between 0.58 to
0.66 and 0.29 to 0.33, respectively. Mean organ doses for two‐view unilateral imag-
ing were 0.24 (CM) and 0.18 (TM) μGy/mAs for the eye lens and 0.24 (CM) and
0.25 (TM) μGy/mAs for the thyroid gland. Higher organ doses were observed during
TM compared to CM as the automatic exposure control (AEC) system resulted in
greater total mAs values in TM.
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1 | INTRODUCTION
Digital breast tomosynthesis (DBT) is a 3D imaging system that
tends to be predominantly used as a diagnostic mammogram for clin-
ical symptoms and as an alternative tool for breast cancer screen-
ing.1,2 The advantages of DBT have been confirmed by several
studies1–4 and include superior early detection of small cancer, lower
recall rate, and improved visualization of breast abnormalities. How-
ever, radiation risk from mammography is a significant concern
among patients, especially among those undergoing routine breast
screening, and their physicians.5 Therefore, one study by Chetlen et
al.6 quantified exposure in five organs of interest during a routine
digital mammography (DM) procedure and disseminated this infor-
mation to health care providers. They evaluated scatter doses at the
skin surface overlaying these five organs in 207 patients using opti-
cally stimulated luminescence dosimeters (OSLDs), and found that
the mean doses at the sternum, the thyroid gland, the salivary gland,
the eye lens, and the uterus were 870, 245, 200, 25, and 11 μGy,
respectively. Recently, another study used Monte‐Carlo simulations
on organ doses from a specific DBT system and reports an increase
of up to 21% in thyroid gland and 9% in lung (ipsilateral) during DBT
acquisition compared to DM acquisition.7 However, those organ
doses were quantified only from the craniocaudal (CC) view and
highly radiosensitive organs such as the eye lens were not
considered.
The DBT system provides dual acquisition modes based on DM
or DBT acquisitions as there are geometric differences in the acqui-
sition setup between these two modes. Specifically, while the x‐ray
tube rotates across a compressed breast within a limited angle range
during DBT acquisition, it remains fixed during DM acquisition,8 and
the absorbed dose at each acquisition mode also varies when used
with the automatic exposure control (AEC) system.7,9 These differ-
ences should be taken into account for estimating scattered dose at
organs of interest during DBT imaging. Currently, OSLDs play an
importance role in point dose measurement during both radiotherapy
and diagnostic imaging due to their characteristics such as high sen-
sitivity, small size, tissue equivalence density, and reusability. While
McKeever et al.10 have reported that OSLDs are capable of measur-
ing doses as low as 10 μGy, linear response among commercially
available OSLDs starts at approximately 50 μGy. In addition, previ-
ous studies11,12 have demonstrated the feasibility of using commer-
cial OSLDs in the mammography energy range by adding a
correction factor.
Thus, this study aimed to measure and compare scatter doses
between DM and DBT acquisitions from a specific DBT system and
to estimate absorbed doses in the eye lens and the thyroid gland
during two‐view mammography under both DM and DBT modes.
We provide data on scattered doses and organ doses and dis-
cuss variations in these doses and their potential radiation risk
during DM and DBT acquisitions in clinical scenarios.
2 | MATERIALS AND METHODS
A DBT system (MAMMOMAT Inspiration; Siemens Medical Solu-
tions Inc., Erlangen, Germany) with dual acquisition modes for DM
and DBT was used. DM acquisition was used in the conventional
mode (CM) while the DBT acquisition was specified as Tomo mode
(TM) which acquires 25 projections of breast tissue from different
tube angles between −25° and +25° at 2° intervals.
2.A | Radiation dosimeter and correction
The nanoDot OSLD (Landauer Inc., Glenwood, IL, USA) is a small disk
made from carbon‐doped aluminum oxide (Al2O3:C) that is enclosed
within a light tight plastic frame and measures 10 × 10 × 2 mm. It was
used in combination with the microStar reader (Landauer Inc.) for all
dose measurements. The lower limit of detection of this OSLD system
is 46.7 μGy, according to the calibration certificate provided by the
manufacturer. NanoDots were corrected using a parallel‐plate ioniza-
tion chamber (Radcal Corp., Monrovia, CA, USA) for use under specific
conditions encountered in our DBT system while measuring scatter
radiation generated during mammography. Figure 1 illustrates the
experimental setup for nanoDot correction. A 4.5 cm thick breast
phantom (CIRS Inc., Norfolk, VA, USA) with an average glandular tissue
composition of 50% was positioned for CC view at the center of the
image detector with a compression paddle. Five nanoDots were pasted
using thin plastic tape and then attached to a pole such that they were
similarly placed in air. The ionization chamber was attached to a tripod,
and the nanoDots and the ionization chamber were placed symmetri-
cally and laterally at the side of chest wall edge, 4 cm from the center
of image detector and 10 cm away from the chest wall edge, such that
they were positioned mid‐level to the breast phantom (Fig. 1).
The exposure parameters were manually set for the tungsten target
and the rhodium filter combinations (W/Rh) with tube voltages of 27, 28,
and 29 kV and a tube current‐time product of 160 mAs. The breast
phantom was irradiated six times at each exposure setting under CM
operation and the scatter dose was allowed to accumulate in the nano-
Dots for the six irradiations. The nanoDots and the ionization chamber
simultaneously recorded the amount of scatter radiation generated pre-
dominantly from the irradiated breast phantom. NanoDot correction
was repeated twice using a new set of five nanoDots, and finally, all
exposed nanoDots were read consecutively three times along with three
control nanoDots in the microStar reader to reduce measurement uncer-
tainty; the average of the three readings from each nanoDot was used
for calculating the correction factor of the nanoDot (CFOSLD) as
CFOSLD ¼ KICKOSLD  BG (1)
where KIC is average air kerma from the ionization chamber (mGy),
KOSLD is average air kerma readout from the five nanoDots (mGy), and
BG is average background readout from the control nanoDots (mGy).
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2.B | Entrance surface air kerma measurements
Entrance surface air kerma (ESAK) was measured to characterize
scatter dose during CM and TM. To simulate a patient's head, we
used a custom‐made, polymethyl methacrylate (PMMA) cylindrical
phantom that was 16 cm in height and diameter. Figure 2(a) illus-
trates nanoDot placements on the PMMA phantom; 49 nanoDots
were pasted on surface of the PMMA phantom such that they cov-
ered angles of −90°, −60°, −30°, 0°, +30°, +60°, +90°. These angles
were used based on locations that receive scatter radiation. Each
placement angle group consisted of seven nanoDots placed along the
vertical direction of the phantom with a gap of 1 cm between succes-
sive nanoDots. The fourth nanoDot was marked as 0° and corre-
sponded to the center point on the PMMA phantom. The breast
phantom was positioned at the center of image detector along with
the compression paddle and face shield for CC and mediolateral obli-
que (MLO) view acquisitions. The PMMA phantom was positioned on
a polystyrene box such that the center point was located at a vertical
height of 32.5 cm (a surrogate of eye level of a female RANDO phan-
tom) from the center the breast phantom and horizontal to the mid‐
breast phantom, with the phantom facing as close as possible to the
edge of the chest wall [Fig. 2(b)]. This experimental setting enabled
the nanoDots receive scatter radiation from angles ranging from
−90° to +90° with receiving distances varying from 26.5 to 38.5 cm,
based on the locations of nanoDots [Fig. 2(b)].
The exposure parameters were set for a W/Rh combination of
28 kV and automatic tube current‐time product, and this setting was
chosen for ESAK measurements because, according to manufac-
turer's specification, only the W/Rh combination could be modified
in TM mode and also because the AEC system identified a tube volt-
age of 28 kV as optimal for the 4.5 cm compressed breast phantom.
All ESAK measurements were performed in both CM and TM by
nanoDots and the nanoDots were irradiated thrice during each mea-
surement to increase the amount of scattered dose received. All
F I G . 1 . The experimental setup for
correcting the nanoDots with an ionization
chamber for use under conditions
encountered during scatter dose
measurement.
(a) (b) (c)
F I G . 2 . NanoDot positions onto custom‐made PMMA phantom at various locations to assess differences in scatter dose received according
to angles and distances (a). Scatter radiation dose could be detected from angles of −90° to +90° and at distance ranging from 26.5 to
38.5 cm, depending on the experimental setting; CC view acquisition (b), MLO view acquisition (c).
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nanoDots were read thrice along with the three control nanoDots
(for measurement of background radiation). The actual scatter dose,
in terms of ESAK, was obtained by subtracting background radiation,
dividing them by three, and then correcting them based on the
CFOSLD value for the W/Rh 28 kV spectrum.
2.C | Organ dose conversion factors
The organ dose conversion factor (CFD) for the W/Rh 28 kV spec-
trum was calculated to estimate absorbed doses at organs that
received scatter radiation during the mammogram under both CM
and TM acquisitions. The nanoDots were inserted into left‐ and
right‐sided holes at specific depths in the PMMA phantom (Fig. 3);
specifically, two nanoDots each at a depth of 3 mm and two nano-
Dots at a depth of 10 mm. Other two nanoDots were pasted onto
corresponding locations on the surface of the PMMA phantom.
The positions of the breast and PMMA phantoms and the expo-
sure parameters were identical to ESAK measurements (as described
in Section 2.B). Air kerma at the specified depths and the surface were
measured separately for the CC and the MLO view acquisitions and in
both CM and TM. The air kerma from all exposed nanoDots was mea-
sured by reading them thrice and using background subtraction. The
CFD was defined as the ratio of air kerma at corresponding depths to
surface, and the ratio of mass energy absorption coefficients of tissue
to air, and was quantified using the following expression










where Kdepth is average air kerma (mGy) at a specific depth, Ksurface is









is mass energy absorption coefficient of air (cm2/g). The mass
energy absorption coefficients were obtained from the National
Institute of Standard and Technology (NIST),13 according to the
effective energy of primary beam, which was estimated using the
half value layer of the W/Rh 28 kV spectrum.
2.D | Organ dose estimation
The absorbed doses at the eye lens and the thyroid gland were esti-
mated using the RANDO phantom. A set of 13 nanoDots were
pasted on skin of a female RANDO phantom (Phantom Laboratory,
Salem, NY, USA) with 10 nanoDots around the eyes and three nano-
Dots around the thyroid gland, as shown in Fig. 4(a). Three other
nanoDots were used as controls for measuring background radiation.
The RANDO phantom and the breast phantom were positioned simi-
lar to a patient positioned for CC or MLO views [Figs. 4(b) and 4(c)].
The x‐ray tube gantry was set at 45° projection in the MLO view.
The cranial RANDO phantom was rotated toward the contralateral
side for both CC and MLO views.
Entrance surface air kerma measurements were acquired using
four sets of nanoDots for the CC and the MLO views in CM and
TM, with a tube voltage of 28 kV and W/Rh combination and auto-
matic tube current‐time product settings that were identical to those
used for previous ESAK measurements. Three irradiations were con-
ducted for each measurement to allow sufficient accumulation of
radiation in the nanoDots, and average of three readout values from
each nanoDot, after background subtraction, was divided by three.
The ESAK obtained using the RANDO phantom was used to esti-
mate eye lens and thyroid gland doses using the following equation:
D ¼ ESAK  CFOSLD  CFD (3)
where ESAK is the average air kerma readout from the nanoDots,
CFOSLD is the correction factor of the nanoDots, and CFD is the
organ dose conversion factor.
3 | RESULTS
3.A | NanoDot correction
Scattered radiation sensed by the nanoDots was different from
those of the reference dosimeter by 11.9%–32.5%. The reproducibil-
ity of scattered dose measurement using nanoDots had a coefficient
of variation (CV) of less than 8.7%, as estimated from two measure-
ments. The cumulative scattered dose from six irradiations, CFOSLD,
and CV values are listed in Table 1. The CFOSLD at 28 kV was
applied for all readout values obtained from the nanoDots.
3.B | ESAK measurements
All nanoDot cumulative doses of less than 50 μGy after three irra-
diations were excluded from analysis in this study. The measured
ESAK values in the PMMA phantom are provided in Table 2 and
Fig. 5 shows percentage differences in ESAK per mAs, averaged for
values at identical received distances between TM and CM. Signifi-
cant differences in ESAK during TM were observed between angles
F I G . 3 . The custom‐made PMMA phantom used for air kerma
measurement.
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of −60° and +60°. The ESAK during TM at 0° angle was lower by
a maximum of 16.1% whereas it increased at angles beyond 0° by
a maximum of 20.8%. In the MLO view, ESAK was higher at an
angle of −30° compared to +30° due to the effects of primary
beam projecting from that side of the phantom.
3.C | Organ dose conversion factors
Table 3 shows CFD values specific for the 4.5 cm compressed breast
phantom at the W/Rh 28 kV x‐ray spectrum whose effective energy
of the primary beam was 18.4 keV. The effective energy was calcu-
lated using the half value layer of 0.56 mmAl of the W/Rh 28 kV
spectrum and NIST data. With regard to the mass energy absorption
coefficient of the eye lens and the soft tissue, CFD values were used
for calculating absorbed doses at depths of 3 and 10 mm from the
surface around the patient's head.
3.D | Organ doses
In the RANDO phantom study, negligible radiation doses were
recorded at the eye lens in the contralateral imaging side during
both CM and TM. The absorbed doses at the thyroid gland and eye
lens on the imaging side are shown in Table 4. The organ doses
tended to be higher during TM compared to CM, because of higher
total mAs values observed during TM under AEC operation. Organ
dose values per unit of mAs at the eye lens, estimated during two‐
view unilateral mammography, were 0.24 and 0.18 μGy/mAs for CM
and TM respectively, whereas those for the thyroid gland were
0.24 and 0.25 μGy/mAs for CM and TM, respectively. We found
that the dose per mAs for the eye lens decreased by 30.4% in TM
compared to CM, whereas in the thyroid gland, it increased slightly
by 4.3%.
(a) (b) (c)
F I G . 4 . Locations of the nanoDots when pasted onto the surface of the RANDO phantom (a). The RANDO phantom and breast phantom on
CC (b) and MLO (c) views, positioned with the compression paddle and face shield.
TAB L E 1 Correction factor values for the nanoDots (CFOSLD) during scatter radiation measurement.
Target/Filter Tube voltage (kV) Exposure (mAs)
Mean cumulative
dose (μGy) CFOSLD (SD) Coefficient of variation (%)
W/Rh 27 160 120.8 0.77 (0.07) 8.7
28 160 127.0 0.89 (0.00) 0.2
29 160 160.2 0.80 (0.01) 1.0
SD, standard deviation.
TAB L E 2 The measured ESAK in PMMA phantom.
Image acquisition mode Target/filter Tube voltage (kV) Exposure (mAs)
ESAK (μGy)
CC view MLO view
Conventional W/Rh 28 133.6 ± 1.5 32.3 (16.4, 67.2) 28.0 (16.7, 47.9)
Tomo W/Rh 28 199.3 ± 18.7 42.4 (16.0, 91.1) 33.9 (17.0, 62.8)
Mean ±SD, Mean (minimum, maximum).
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4 | DISCUSSION
We show that the nanoDot response to scatter radiation had a max-
imum variation of 33% compared to the ionization chamber. This
may be explained by the energy dependence of the nanoDot in the
energy range utilized during mammography; this value has been
reported as 10% in the study by Kawaguchi et al.,12 whereas it was
50% in the study by Okazaki et al.14 Specifically, Okazaki et al. have
reported that the relative responses of nanoDots with CdTe detector
at low energy were 0.46 (8.1 keV), 0.87 (16.9 keV), and 1.00
(31.6 keV). Therefore, nanoDots should ideally be corrected for their
energy dependence at doses used in mammography using a refer-
ence dosimeter for more accurate measurement.
We found that the differences in acquisition geometry between
CM and TM had an impact on scattered dose in the PMMA
phantom as TM acquisition involved movement of the x‐ray tube
over the breast phantom which led to distribution of scatter radia-
tion across all projection angles of the incident beam. This led to
lower ESAK per mAs values during TM at a receiving angle of 0° but
yielded higher values at receiving angles greater than 0°. Changes in
ESAK values in the CC view at receiving angles of −30° and +30°
can be explained by inaccurate nanoDot placement, while similar
changes in the MLO view are attributable to acquisition geometry as
the x‐ray tube gantry was set for oblique projection.
We observed that eye lens dose during TM increased due to
greater number of image acquisitions, i.e., 25 projections acquired
with a scan time of 25 s;15 this caused an increase in the tube cur-
rent‐time product in the AEC system. Nonetheless, the difference in
eye lens dose in the Rando phantom was less than 5.0% between
TM (28.5 μGy) and CM (27.1 μGy) even though the total mAs value
in TM (160.9 mAs) was 35.5% higher than in CM (112.4 mAs). It is
also possible that the number of scattered photons from the breast
phantom that reach the eyes were restricted by the energy of the
scattered photon. In contrast, absorbed dose in the thyroid gland
displayed a large difference of 39.7% between TM (40.2 μGy) and
CM (26.9 μGy), possibly because of its anatomically close location to
the breast phantom.
Small discrepancies in ESAK values are observable between our
study and the study by Chetlen et al.6 and can be accounted for
by differences in breast phantom thickness and composition
between the patient population and the breast phantom, and due
to nanoDot placements. Chetlen et al.6 have reported mean breast
thickness and average glandular dose (AGD) in their study popula-
tion to be 6.1 and 1.36 mGy per view, respectively, while mean
ESAK recorded by one nanoDot pasted at the bridge of the nose
(a surrogate of eye lens) during DM in the patient population was
25 μGy in two‐view bilateral mammography. Importantly, even
though the mean ESAK was less than lower detection limit of the
nanoDot (33.5 μGy) in their study, ESAK at the bridge of the nose
was highest at 121 μGy. In our study, one of the RANDO phantom
eyes recorded a higher the mean ESAK (about 86.4 μGy) and the
maximum ESAK value was 131.9 μGy during two‐view bilateral
mammography in CM; essentially, eyes close to the imaged side
received a higher dose whereas the contralateral eye received a
negligible dose, implying that nanoDots should be pasted on eyes
that are close to imaged tissue for improving accuracy of measure-
ment. The positions of nanoDots at thyroid gland in the study by
Chetlen et al.6 are comparable to those employed by us, as they
also pasted two nanoDots on the patient's skin over the right and
the left thyroid lobes. They report mean ESAK of 245 μGy for the
thyroid gland which is similar to our value of 174.9 μGy when dif-
ferences in compressed breast thickness are taken into account
(6.1 vs. 4.5 cm).
On the other hand, large discrepancies in organ doses are seen
between values obtained by direct measurement in our study and
those obtained by the Monte‐Carlo simulation in other studies. Bap-
tista et al.7 have reported thyroid gland doses of 273 μGy for two








-90 -60 -30 0 30 60 90
CC view
MLO view
Relative ESAK/mAs changed in Tomo mode (%)
Received 
angle (°)
F I G . 5 . The percent differences in ESAK per mAs between
conventional (CM) and Tomo modes (TM) as a function of receiving
angles.
TAB L E 3 The organ dose conversion factors (CFD) for the eye lens
and the thyroid gland.
Image
acquisition
Conventional mode Tomo mode
Eye lens Thyroid gland Eye lens Thyroid gland
CC view 0.66 (0.04) 0.29 (0.01) 0.59 (0.00) 0.32 (0.02)
MLO view 0.59 (0.06) 0.33 (0.03) 0.58 (0.04) 0.30 (0.00)
Mean (SE).
TAB L E 4 The eye lens and thyroid gland doses recorded during













Conventional 28 112.4 ± 15.3 27.1 ± 4.6 26.9 ± 2.9
Tomo 28 160.9 ± 21.4 28.5 ± 5.0 40.2 ± 5.3
Mean ± SD.
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acquisition; these are almost ten times higher than those measured
in our study (29.7 μGy in CM and 47.7 μGy in TM). Procedural varia-
tions can account for this difference as the other studies used a
female voxel phantom, a computational phantom based on seg-
mented images of a 43‐year‐old patient, and assumed an AGD of
2 mGy for a W/Rh 28 kV x‐ray spectrum for the imaged breast. Thy-
roid gland doses were calculated relative to the AGD in DM and
DBT acquisitions wherein the irradiated beam was simulated for 25
projections at an angular range between −24° and +24° during DBT.
Additionally, data on either breast thickness or compression of the
phantom were absent in these reports. These details are crucial as, if
the phantom breast was not compressed, it may generate more scat-
ter radiation from the breast and result in higher absorbed dose in
the peripheral organs. However, they report an increasing trend in
thyroid gland dose during tomosynthesis acquisition which is consis-
tent with the results from our study. Sechopoulos et al.16 have also
used a computational phantom (Cristy phantom) after modifying its
elemental composition and tissue densities, and addition of eyes, eye
lens, and sternum to the phantom. They used a model that incorpo-
rated a compressed breast with 50% glandularity in both CC
(5.2 cm) and MLO (5.7 cm) views and assumed glandular doses of
2.0 and 2.5 mGy for the CC and MLO views, respectively. Further,
eye lens dose was normalized to breast glandular dose, which then
yielded a maximum eye lens dose of 4.4 μGy for two‐view unilateral
mammography using the Rh/Rh 35 kV x‐ray spectrum. This value is
nearly six times lower than that reported here (27.1 μGy in CM).
These discrepancies in scattered dose values between direct mea-
surement and Monte‐Carlo simulations can be accounted for by vari-
ations in phantom characteristics and mammographic positioning
associated with using a real phantom versus computational phan-
toms. Authors of the previous studies, namely, Baptista and Secho-
poulos, concur that computational phantoms have limitations in their
ability to describe the complex shape encountered in real organs (3D
shape) and that such phantoms may deviate from the body habitus
of patients. Therefore, using such computational phantoms can
potentially introduce significant error in estimated organ dose.16
Additionally, in study by Castellano et al.,17 discrepancies of about
38% in estimated dose are seen between the Cristy phantom and
the voxel base phantom, and estimated absorbed dose values at the
left lung (ipsilateral) reported by the studies of Baptista7 and Secho-
poulos16 are 385 and 4.4 μGy respectively, even though assumed
AGD was similar in both studies.
Our results definitively show that exposure of the eye lens and
the thyroid gland cannot be avoided during mammography, either in
CM or TM, despite the presence of a face shield. Nevertheless,
these doses were in the μGy range which is extremely small and
seems negligible when compared to the fact that the current thresh-
old dose for a significant risk to organs such as the lens is 0.5 Gy, as
suggested by the International Commission on Radiological Protec-
tion (ICRP).18 Further, the thyroid gland is considered less radiosensi-
tive compared to the eye lens.
The above notwithstanding, there are limitations to this study.
We used a specific breast phantom with breast thickness of 4.5 cm
and breast composition of 50% glandular tissue and 50% adipose tis-
sue, and a defined x‐ray spectrum, which is not completely compati-
ble with the clinical scenario where women who undergo
mammography have various breast thicknesses and densities. These
factors lead to the use of a variety of x‐ray spectra for mammogra-
phy. For instance, a higher energy spectrum is usually used for thick
breasts than that used for the average breast; this may lead to an
increase in scattered dose at peripheral organs. Moreover, uncer-
tainty in our results may have occurred due to the angular depen-
dence of nanoDots as we report about 5% difference in scatter
radiation compared to Monte‐Carlo simulation‐based measurements
by Okazaki et al.14
5 | CONCLUSION
Entrance surface air kerma measurements using OSLDs in a speci-
fic DBT system were compared between TM and CM and the
observed variation in ESAK values between CM and TM was due
to rotation of the x‐ray tube during tomosynthesis acquisition.
Organ doses were normalized by multiplying ESAK measured in
the Rando phantom and estimated conversion factors. Eye lens
dose per mAs was lower by 30.4% whereas thyroid gland dose
per mAs was higher by 4.3% in TM compared to CM. Organ
doses estimated during two‐view unilateral imaging were higher in
TM compared to CM due to greater number of image acquisi-
tions in TM; these led to a higher total mAs value under AEC
operation.
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